Elliot Turner, Managing Partner and CIO of RGIA Investment Advisors, returns to The Business Brew for a great conversation. To start, Bill and Elliot discuss what Elliot learned from the period of 2021 to now. They then discuss some specific stock ideas, thoughts on portfolio management, and much more. We hope you enjoy. Note: This episode was recorded on April 3, 2024. Bill owns a small position in Fevertree (established after recording) and a basket of positions in some smaller life science companies. Detailed Show Notes: 3:00 - Learnings 10:30 - Prioritizing health to lead to success 14:00 - Was it an everything bubble? 22:15 - Fevertree discussion 37:40 - Thoughts on position sizing 44:30 - Incentives in finance papers 49:00 - A great NVDA story 55:00 - Is life sciences similar to tech after 2000 58:50 - The 3 forces that make life sciences and biotech interesting for humanity 1:08:00 - Is The Street focused on the wrong things? 1:16:20 - Maravai 1:25:00 - Thinking about patent cliffs 1:29:00 - High costs of failure and why that may be a good opportunity for existing suppliers
